Determination of 1-(2-chloroethyl)-3-(2,6-dioxo-3-piperidyl)-1-nitrosourea in plasma by negative chemical ionization mass spectrometry

R. G. Smith, L. K. Cheung, Lynn G Feun, T. L. Loo

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

A sensitive and specific method for the quantitative determination of a new antitumor agent, 1-(2-chloroethyl)-3-(2,6-dioxo-3-piperidyl)-1-nitrosourea, (PCNU) has been developed for the analysis of plasma. This assay involves extraction of the plasma sample, separation of the drug by thin-layer chromatography and mass spectrometric detection of the negative ions derived from the unchanged drug and its 2H4-labeled analog. Ion current profile peaks are obtained when drug samples are introduced into the heated source using a desorption chemical ionization probe. Detection limits are below 1.0 ng ml-1 of plasma. This method has been applied to determine the in vitro rate of decomposition of PCNU in plasma and the plasma clearance of this drug from a cancer patient.

Original languageEnglish
Pages (from-to)404-407
Number of pages4
JournalBiomedical Mass Spectrometry
Volume10
Issue number7
StatePublished - Dec 1 1983
Externally publishedYes

Fingerprint

Ionization
Mass spectrometry
Mass Spectrometry
Plasmas
Pharmaceutical Preparations
Ions
Thin layer chromatography
Thin Layer Chromatography
Antineoplastic Agents
Limit of Detection
Assays
Desorption
Negative ions
Decomposition
Neoplasms
1-(2-chloroethyl)-3-(2,6-dioxo-3-piperidinyl)-1-nitrosourea

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Medicine
  • Pollution

Cite this

Determination of 1-(2-chloroethyl)-3-(2,6-dioxo-3-piperidyl)-1-nitrosourea in plasma by negative chemical ionization mass spectrometry. / Smith, R. G.; Cheung, L. K.; Feun, Lynn G; Loo, T. L.

In: Biomedical Mass Spectrometry, Vol. 10, No. 7, 01.12.1983, p. 404-407.

Research output: Contribution to journalArticle

@article{a2449c3c930c416cb4f516172cf99275,
title = "Determination of 1-(2-chloroethyl)-3-(2,6-dioxo-3-piperidyl)-1-nitrosourea in plasma by negative chemical ionization mass spectrometry",
abstract = "A sensitive and specific method for the quantitative determination of a new antitumor agent, 1-(2-chloroethyl)-3-(2,6-dioxo-3-piperidyl)-1-nitrosourea, (PCNU) has been developed for the analysis of plasma. This assay involves extraction of the plasma sample, separation of the drug by thin-layer chromatography and mass spectrometric detection of the negative ions derived from the unchanged drug and its 2H4-labeled analog. Ion current profile peaks are obtained when drug samples are introduced into the heated source using a desorption chemical ionization probe. Detection limits are below 1.0 ng ml-1 of plasma. This method has been applied to determine the in vitro rate of decomposition of PCNU in plasma and the plasma clearance of this drug from a cancer patient.",
author = "Smith, {R. G.} and Cheung, {L. K.} and Feun, {Lynn G} and Loo, {T. L.}",
year = "1983",
month = "12",
day = "1",
language = "English",
volume = "10",
pages = "404--407",
journal = "Journal of Mass Spectrometry",
issn = "1076-5174",
publisher = "John Wiley and Sons Ltd",
number = "7",

}

TY - JOUR

T1 - Determination of 1-(2-chloroethyl)-3-(2,6-dioxo-3-piperidyl)-1-nitrosourea in plasma by negative chemical ionization mass spectrometry

AU - Smith, R. G.

AU - Cheung, L. K.

AU - Feun, Lynn G

AU - Loo, T. L.

PY - 1983/12/1

Y1 - 1983/12/1

N2 - A sensitive and specific method for the quantitative determination of a new antitumor agent, 1-(2-chloroethyl)-3-(2,6-dioxo-3-piperidyl)-1-nitrosourea, (PCNU) has been developed for the analysis of plasma. This assay involves extraction of the plasma sample, separation of the drug by thin-layer chromatography and mass spectrometric detection of the negative ions derived from the unchanged drug and its 2H4-labeled analog. Ion current profile peaks are obtained when drug samples are introduced into the heated source using a desorption chemical ionization probe. Detection limits are below 1.0 ng ml-1 of plasma. This method has been applied to determine the in vitro rate of decomposition of PCNU in plasma and the plasma clearance of this drug from a cancer patient.

AB - A sensitive and specific method for the quantitative determination of a new antitumor agent, 1-(2-chloroethyl)-3-(2,6-dioxo-3-piperidyl)-1-nitrosourea, (PCNU) has been developed for the analysis of plasma. This assay involves extraction of the plasma sample, separation of the drug by thin-layer chromatography and mass spectrometric detection of the negative ions derived from the unchanged drug and its 2H4-labeled analog. Ion current profile peaks are obtained when drug samples are introduced into the heated source using a desorption chemical ionization probe. Detection limits are below 1.0 ng ml-1 of plasma. This method has been applied to determine the in vitro rate of decomposition of PCNU in plasma and the plasma clearance of this drug from a cancer patient.

UR - http://www.scopus.com/inward/record.url?scp=0020964736&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0020964736&partnerID=8YFLogxK

M3 - Article

C2 - 6616018

AN - SCOPUS:0020964736

VL - 10

SP - 404

EP - 407

JO - Journal of Mass Spectrometry

JF - Journal of Mass Spectrometry

SN - 1076-5174

IS - 7

ER -